You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

t-dm1

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-positive Breast Cancer, Breast Cancer, Breast Cancer Stage Trial in United States (Palbociclib, T-DM1)

Completed
  • HER2-positive Breast Cancer
  • +5 more
  • Tucson, Arizona
  • +15 more
Dec 22, 2022

Breast Cancer Trial in Boston (T-DM1, Pembrolizumab)

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +1 more
Jul 25, 2022

HER-2 Positive Breast Cancer, Breast Cancer, Stage II Breast Cancer Trial in Boston, Nashville (T-DM1, Pertuzumab, Excision of

Active, not recruiting
Has Results
  • HER-2 Positive Breast Cancer
  • +3 more
  • T-DM1
  • +2 more
  • Boston, Massachusetts
  • +3 more
Mar 4, 2022

Breast Cancer Trial in United States (T-DM1)

Active, not recruiting
  • Breast Cancer
  • T-DM1
  • Duarte, California
  • +13 more
Aug 25, 2022

Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II Trial in Charlottesville (T-DM1, Capecitabine, External Beam

Not yet recruiting
  • Breast Cancer
  • +3 more
  • T-DM1
  • +3 more
  • Charlottesville, Virginia
    University of Virginia
Apr 12, 2022

HER2+ Breast Cancer Trial in Xi'an (Trastuzumab, Pertuzumab, Nab paclitaxel)

Recruiting
  • HER2+ Breast Cancer
  • Xi'an, Shaanxi, China
  • +1 more
Jun 20, 2022

Breast Cancer Trial in Anaheim, Glendale (Poziotinib, T-DM1)

Terminated
  • Breast Cancer
  • Anaheim, California
  • +1 more
Jan 14, 2021

Breast Cancer Invasive Trial in Shanghai (Pyrotinib, Trastuzumab, Pertuzumab)

Active, not recruiting
  • Breast Cancer Invasive
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022

Breast Cancer Trial in Houston, Sugar Land (T-DM1, Trastuzumab, Lapatinib)

Completed
Has Results
  • Breast Cancer
  • T-DM1
  • +5 more
  • Houston, Texas
  • +2 more
Aug 27, 2021

HER2 Positive Breast Cancers Trial in Canada, United States (Tucatinib (ONT-380), T-DM1)

Completed
  • HER2 Positive Breast Cancers
  • Tucatinib (ONT-380)
  • T-DM1
  • Birmingham, Alabama
  • +10 more
Sep 17, 2020

HER2-positive Breast Cancer, Brain Metastases Trial in China (Afatinib, T-DM1)

Recruiting
  • HER2-positive Breast Cancer
  • Brain Metastases
  • Beijing, Beijing, China
  • +3 more
May 9, 2020

HER2-positive Breast Cancer, Breast Cancer Metastatic Trial in Kansas City, Overland Park, Lee's Summit (Palbociclib 75mg,

Active, not recruiting
  • HER2-positive Breast Cancer
  • Breast Cancer Metastatic
  • Palbociclib 75mg
  • +5 more
  • Kansas City, Kansas
  • +4 more
Nov 23, 2020

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab, Pertuzumab, Paclitaxel)

Completed
  • Metastatic Breast Cancer
  • Amiens, France
  • +70 more
Mar 29, 2021

HER2-positive Breast Cancer Trial in Worldwide (tucatinib, , T-DM1)

Recruiting
  • HER2-positive Breast Cancer
  • Mobile, Alabama
  • +262 more
Jan 26, 2023

HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer Trial in Worldwide (DS-8201a, T-DM1)

Recruiting
  • HER2-Positive Primary Breast Cancer
  • Residual Invasive Breast Cancer
  • Anaheim, California
  • +505 more
Feb 2, 2023

Breast Cancer Trial in Munich, Mönchengladbach (T-DM1, Trastuzumab)

Unknown status
  • Breast Cancer
  • Munich, Germany
  • +1 more
Jul 20, 2019

Metastatic Breast Cancer Trial in Houston (T-DM1, Lapatinib, Abraxane)

Completed
  • Metastatic Breast Cancer
  • T-DM1
  • +2 more
  • Houston, Texas
    Houston Methodist Hospital
Apr 12, 2019

HER-2 Positive Breast Cancer Trial in Belgium, Netherlands (T-DM1, 89Zr-trastuzumab)

Unknown status
  • HER-2 Positive Breast Cancer
  • T-DM1
  • 89Zr-trastuzumab
  • Antwerpen, Edegem, Belgium
  • +4 more
Nov 26, 2018